文献速递消化、代谢与肾脏急症心脑血管急症

预防性抗胆碱能药物减少急性止吐药所致锥体外系副作用:系统评价与荟萃分析

Effects of prophylactic anticholinergic medications to decrease extrapyramidal side effects in patients taking acute antiemetic drugs: a systematic review and meta-analysis.
PubMed 文献 · Emerg Med J · 2018-02-03
一句话结论在急性偏头痛使用多巴胺D2受体拮抗剂止吐药时,15分钟输注且不预防性使用苯海拉明可最低限度减少锥体外系症状且避免镇静。

该系统评价与荟萃分析纳入4项安慰剂对照随机对照试验共737例急性偏头痛患者,评估预防性抗胆碱能药物对多巴胺D2受体拮抗剂止吐药所致锥体外系症状的效果。当止吐药以2分钟弹丸式注射给药时,苯海拉明组锥体外系症状风险显著低于安慰剂组(OR 0.42,95%CI 0.22-0.81,P=0.01);而以15分钟输注给药时,用与不用苯海拉明无显著差异(OR 1.06,95%CI 0.58-1.91,P=0.85)。接受15分钟输注且未预防性使用苯海拉明的患者锥体外系症状发生率最低(9.8%)。两项试验共351例报告镇静评分,苯海拉明组镇静发生率显著更高(31.6% vs 19.2%,OR 2.01,95%CI 1.21-3.33,P=0.007)。作者结论认为,最有效策略是将D2拮抗剂止吐药以15分钟输注给药且不进行预防。

要点

  • 急性偏头痛使用多巴胺D2受体拮抗剂止吐药时,2分钟弹丸式注射联合苯海拉明预防可显著降低锥体外系症状风险(OR 0.42,95%CI 0.22-0.81,P=0.01)。
  • 止吐药以15分钟输注给药时,联合苯海拉明与安慰剂相比锥体外系症状无显著差异(OR 1.06,95%CI 0.58-1.91,P=0.85)。
  • 接受15分钟输注且未用苯海拉明预防的患者锥体外系症状发生率最低(9.8%)。
  • 苯海拉明预防显著增加镇静发生率(31.6% vs 19.2%,OR 2.01,95%CI 1.21-3.33,P=0.007)。
  • 作者结论:最有效策略是将D2拮抗剂止吐药以15分钟输注给药且不进行预防性抗胆碱能治疗。

适用人群与场景

  • 因急性偏头痛接受具有多巴胺D2受体拮抗作用的止吐药治疗的患者(纳入的随机对照试验人群)。

处置流程与药物剂量

  • 当止吐药以2分钟弹丸式注射给药时,预防性使用苯海拉明可降低锥体外系症状风险(OR 0.42,95%CI 0.22-0.81,P=0.01)。
  • 当止吐药以15分钟输注给药时,不预防性使用苯海拉明(锥体外系症状发生率9.8%,为最低)。
  • 作者结论:最有效策略是将D2拮抗剂止吐药以15分钟输注给药且不进行预防,因苯海拉明显著增加镇静(31.6% vs 19.2%,OR 2.01,95%CI 1.21-3.33,P=0.007)。

研究设计与关键结果

  • 研究类型:系统评价与荟萃分析,纳入4项安慰剂对照随机对照试验,共737例患者。
  • 主要结果:2分钟弹丸式注射止吐药时,苯海拉明组锥体外系症状风险显著低于安慰剂组(OR 0.42,95%CI 0.22-0.81,P=0.01);15分钟输注时,苯海拉明与安慰剂无显著差异(OR 1.06,95%CI 0.58-1.91,P=0.85)。
  • 关键次要终点:接受15分钟输注且未用苯海拉明预防的患者锥体外系症状发生率最低(9.8%)。
  • 不良事件:两项试验共351例报告镇静评分,苯海拉明组镇静发生率显著高于对照组(31.6% vs 19.2%,OR 2.01,95%CI 1.21-3.33,P=0.007)。

证据类型、等级与局限

  • 证据类型:系统评价与荟萃分析,纳入4项随机对照试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于因急性偏头痛接受多巴胺D2受体拮抗剂止吐药的患者,若采用2分钟弹丸式注射,可考虑预防性使用苯海拉明以降低锥体外系症状风险(OR 0.42,95%CI 0.22-0.81,P=0.01)。
  • 若采用15分钟输注给药,预防性使用苯海拉明未显著降低锥体外系症状(OR 1.06,95%CI 0.58-1.91,P=0.85),且苯海拉明组镇静发生率显著更高(31.6% vs 19.2%,OR 2.01,95%CI 1.21-3.33,P=0.007)。
  • 作者认为最有效策略是将D2拮抗剂止吐药以15分钟输注给药且不进行预防性抗胆碱能治疗。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To determine the effectiveness of prophylactic anticholinergic medications in reducing extrapyramidal symptoms in patients taking acute antiemetics with a dopamine D2 receptor antagonist effect.

METHODS: Systematic searches of all published studies through March 2017 were identified from PubMed, Cochrane library, Embase, Web of Science and Scopus. Only randomised controlled trials of patients receiving dopamine D2 antagonist antiemetic therapy for acute migraine in which an anticholinergic or placebo was compared were included. Pooled ORs were calculated for incidence of extrapyramidal symptoms and sedation.

RESULTS: Four placebo-controlled randomised controlled trials consisting of 737 patients met the inclusion criteria for our meta-analysis. The effect of diphenhydramine differed depending on the method of administration of the antiemetic. When the antiemetic was delivered as a 2 min antiemetic bolus, the odds of extrapyramidal symptoms were significantly reduced in the diphenhydramine group compared with placebo (OR 0.42; 95% CI 0.22 to 0.81; P=0.01). However, when the antiemetic was given as a 15 min infusion, there was no significant difference in extrapyramidal symptoms with or without diphenhydramine (OR 1.06; 95% CI 0.58 to 1.91; P=0.85). The lowest incidence of extrapyramidal symptoms was observed in patients receiving a 15 min antiemetic infusion without diphenhydramine prophylaxis (9.8%). In two trials including 351 patients that dichotomously reported sedation scales, diphenhydramine had significantly higher rates of sedation (31.6%vs19.2%, OR 2.01, 95% CI 1.21 to 3.33; P=0.007).

CONCLUSION: Prophylactic diphenhydramine reduces extrapyramidal symptoms in patients receiving bolus antiemetic therapy with a dopamine D2 antagonist effect, but not when it is given as an infusion. Because of significantly greater sedation with diphenhydramine, the most effective strategy is to administer the D2 antagonist antiemetic as a 15 min infusion without prophylaxis.

来源:Emerg Med J,查看原文。版权归原作者所有。

参考来源

  1. D'Souza RS, Mercogliano C, Ojukwu E, et al. Effects of prophylactic anticholinergic medications to decrease extrapyramidal side effects in patients taking acute antiemetic drugs: a systematic review and meta-analysis. Emerg Med J. 2018. PMID: 29431143. doi:10.1136/emermed-2017-206944

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。